240 related articles for article (PubMed ID: 35090076)
1. Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.
Lei Y; Han P; Chen Y; Wang H; Wang S; Wang M; Liu J; Yan W; Tian D; Liu M
Clin Transl Med; 2022 Jan; 12(1):e686. PubMed ID: 35090076
[TBL] [Abstract][Full Text] [Related]
2. Decreased nitric oxide content mediated by asymmetrical dimethylarginine and protein l-arginine methyltransferase 3 in macrophages induces trophoblast apoptosis: a potential cause of recurrent miscarriage.
Hao F; Tang LC; Sun JX; Li WX; Zhao Y; Xu XH; Jin LP
Hum Reprod; 2021 Nov; 36(12):3049-3061. PubMed ID: 34647126
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.
Hsu MC; Tsai YL; Lin CH; Pan MR; Shan YS; Cheng TY; Cheng SH; Chen LT; Hung WC
J Hematol Oncol; 2019 Jul; 12(1):79. PubMed ID: 31324208
[TBL] [Abstract][Full Text] [Related]
4. Matrine suppresses hepatocellular carcinoma tumorigenesis by modulating circ_0055976/miR-1179/lactate dehydrogenase A axis.
Chang X; Li H; Huang Z; Song C; Zhang Z; Pan W
Environ Toxicol; 2024 Mar; 39(3):1481-1493. PubMed ID: 37994612
[TBL] [Abstract][Full Text] [Related]
5. PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Shi Y; Niu Y; Yuan Y; Li K; Zhong C; Qiu Z; Li K; Lin Z; Yang Z; Zuo D; Qiu J; He W; Wang C; Liao Y; Wang G; Yuan Y; Li B
Nat Commun; 2023 Apr; 14(1):1932. PubMed ID: 37024475
[TBL] [Abstract][Full Text] [Related]
6. PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.
Wang Y; Wang C; Guan X; Ma Y; Zhang S; Li F; Yin Y; Sun Z; Chen X; Yin H
Adv Sci (Weinh); 2023 Dec; 10(36):e2303812. PubMed ID: 37973560
[TBL] [Abstract][Full Text] [Related]
7. PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.
Liao Y; Luo Z; Lin Y; Chen H; Chen T; Xu L; Orgurek S; Berry K; Dzieciatkowska M; Reisz JA; D'Alessandro A; Zhou W; Lu QR
Cell Death Dis; 2022 Nov; 13(11):943. PubMed ID: 36351894
[TBL] [Abstract][Full Text] [Related]
8. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.
Chen W; Li Y; Zhong J; Wen G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589
[TBL] [Abstract][Full Text] [Related]
9. MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma.
Wang X; Zhang P; Deng K
Anal Cell Pathol (Amst); 2022; 2022():1435173. PubMed ID: 36033372
[TBL] [Abstract][Full Text] [Related]
10. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
11. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
13. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
14. IRF5 promotes glycolysis in the progression of hepatocellular carcinoma and is regulated by TRIM35.
Fang Y; Lu ZH; Liu BZ; Li N; Yang MZ; Wang P
J Dig Dis; 2023; 24(8-9):480-490. PubMed ID: 37594849
[TBL] [Abstract][Full Text] [Related]
15. A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).
Kaniskan HÜ; Szewczyk MM; Yu Z; Eram MS; Yang X; Schmidt K; Luo X; Dai M; He F; Zang I; Lin Y; Kennedy S; Li F; Dobrovetsky E; Dong A; Smil D; Min SJ; Landon M; Lin-Jones J; Huang XP; Roth BL; Schapira M; Atadja P; Barsyte-Lovejoy D; Arrowsmith CH; Brown PJ; Zhao K; Jin J; Vedadi M
Angew Chem Int Ed Engl; 2015 Apr; 54(17):5166-70. PubMed ID: 25728001
[TBL] [Abstract][Full Text] [Related]
16. PRMT3 methylates HIF-1α to enhance the vascular calcification induced by chronic kidney disease.
Zhou G; Zhang C; Peng H; Su X; Huang Q; Zhao Z; Zhao G
Mol Med; 2024 Jan; 30(1):8. PubMed ID: 38200452
[TBL] [Abstract][Full Text] [Related]
17. Zebrafish prmt3 negatively regulates antiviral responses.
Zhu J; Liu X; Cai X; Ouyang G; Zha H; Zhou Z; Liao Q; Wang J; Xiao W
FASEB J; 2020 Aug; 34(8):10212-10227. PubMed ID: 32643209
[TBL] [Abstract][Full Text] [Related]
18. PGC1β regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism.
Zhang H; Li L; Chen Q; Li M; Feng J; Sun Y; Zhao R; Zhu Y; Lv Y; Zhu Z; Huang X; Xie W; Xiang W; Yao P
Mol Oncol; 2018 Sep; 12(9):1579-1595. PubMed ID: 30051603
[TBL] [Abstract][Full Text] [Related]
19. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
20. Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648.
Min Z; Xiaomeng L; Zheng L; Yangge D; Xuejiao L; Longwei L; Xiao Z; Yunsong L; Ping Z; Yongsheng Z
Cell Death Dis; 2019 Aug; 10(8):581. PubMed ID: 31378783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
